INTERNATIONAL PATENT: CROSSLINK THERAPEUTICS INC. FILES APPLICATION FOR "ATP-DEPENDENT AGONISTS OF IMMUNE CELLS FUNCTION AS ANTICANCER AGENTS"

GENEVA, March 19 -- CROSSLINK THERAPEUTICS INC. (244 Pearl StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2024/045722) for "ATP-DEPENDENT AGONISTS OF IMMUNE CELLS FUNCTION AS ANTICANCER AGENTS" on Sep 06, 2024. With publication no. WO/2025/054553, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SEIDEL, Ronald D., III (c/o Crosslink Therapeutics Inc.244 Pearl StreetCambridge, Massachusetts 02139), CHAPARRO, Rodolfo J. (c/o Crosslink Therapeutics Inc.244 Pearl StreetCambridge, Massachusetts 02139), ...